These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 30323202)
1. Distinct co-expression networks using multi-omic data reveal novel interventional targets in HPV-positive and negative head-and-neck squamous cell cancer. Costa RL; Boroni M; Soares MA Sci Rep; 2018 Oct; 8(1):15254. PubMed ID: 30323202 [TBL] [Abstract][Full Text] [Related]
2. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma. Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058 [TBL] [Abstract][Full Text] [Related]
3. HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer. Mehdi AM; Zhou C; Turrell G; Walpole E; Porceddu S; Frazer IH; Chandra J Cancer Gene Ther; 2023 Apr; 30(4):629-640. PubMed ID: 36575316 [TBL] [Abstract][Full Text] [Related]
4. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma. Yang Y; Feng L; Wang R; Ma H; He S; Fang J Medicine (Baltimore); 2022 Aug; 101(33):e26120. PubMed ID: 35984201 [TBL] [Abstract][Full Text] [Related]
7. Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859 [TBL] [Abstract][Full Text] [Related]
8. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma. Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879 [TBL] [Abstract][Full Text] [Related]
9. Identification of hub genes and potential therapeutic mechanisms related to HPV positive head and neck squamous carcinoma based on full transcriptomic detection and ceRNA network construction. Wang K; Zhang T; Li X; Zhang X; Li R; Pan B; Deng J Gene; 2024 Jun; 910():148321. PubMed ID: 38428621 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of activation of the LIMD1-VHL-HIF1α pathway during head-&-neck squamous cell carcinoma development. Mukhopadhyay D; Chakraborty B; Sarkar S; Alam N; Panda CK Indian J Med Res; 2024 May; 159(5):479-493. PubMed ID: 39382421 [TBL] [Abstract][Full Text] [Related]
12. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma. Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359 [TBL] [Abstract][Full Text] [Related]
13. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272 [TBL] [Abstract][Full Text] [Related]
14. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis. Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas. Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062 [TBL] [Abstract][Full Text] [Related]
16. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes in head and neck squamous cell carcinoma. Jin Y; Qin X Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894857 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation association with stage progression of head and neck squamous cell carcinoma. Ghafarpour V; Khansari M; Banaei-Moghaddam AM; Najafi A; Masoudi-Nejad A Comput Biol Med; 2021 Jul; 134():104473. PubMed ID: 34034219 [TBL] [Abstract][Full Text] [Related]
20. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma. Jin Y; Qin X Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]